GLP-1 weight loss drugs will be available for Medicare patients for $50 a month, President Trump announced Friday. The coverage would begin July 1, he said. More than 66 million people in the U.S. get ...
Weight loss drug brands Ozempic, Wegovy and Mounjaro have risen sharply in popularity in the US, but they are still considered unaffordable.
Medicare’s proposed pilot to cover GLP-1 drugs like Wegovy and Zepbound has been delayed.
The disclosure forms bear Trump’s signature. They show seven purchases of Lilly stock made on the president’s behalf through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results